PHI with Submandibular gland cancer

How does this condition affect your private health insurance?

Unterkieferspeicheldrüsenkrebs, or submandibular gland cancer, is a rare malignancy originating in the submandibular salivary gland located beneath the jaw. It typically presents as a painless or sometimes tender lump in the neck or under the jaw. Other symptoms may include difficulty swallowing, facial nerve weakness, or persistent pain. Diagnosis involves imaging like MRI or CT, followed by fine-needle aspiration or biopsy. Treatment primarily consists of surgical removal of the gland, often with neck dissection, potentially followed by radiation therapy. Prognosis depends on the tumor's stage, grade, and histological type, with early detection improving outcomes. This cancer requires meticulous staging and individualized treatment planning to manage its localized and potential metastatic spread effectively.

PKV Risk Assessment

Very High Risk of Rejection

Individual, specialized PHI providers may still insure you, but with a significant surcharge.

Impact on Your Insurance Policy

Duration of Illness (Initial)

Several weeks to a few months for diagnosis and initial treatment (surgery, radiation).

Duration of Illness (Lifetime)

Chronic disease with lifelong monitoring and potential for recurrence; not a one-time event.

Cost of Treatment (Initial)

High, typically ranging from 30,000 to over 150,000 USD/EUR, depending on the extent of surgery and adjuvant therapies.

Cost of Treatment (Lifetime)

Very high, potentially several hundred thousand USD/EUR, including long-term follow-up, management of side effects, and treatment for potential recurrence or metastasis.

Mortality Rate

Moderate to high, highly dependent on the stage, grade, and histological type of the tumor at diagnosis. Ranges from less than 10% for early-stage, low-grade tumors to over 50% for advanced or aggressive forms within 5 years.

Risk of Secondary Damages

High. Potential physical damage includes facial nerve paralysis, swallowing difficulties, chronic dry mouth (if radiation is used), pain, and disfigurement. Psychological impact due to cancer diagnosis and treatment side effects is also common.

Probability of Full Recovery

Moderate. While complete remission is possible, particularly with early detection and comprehensive treatment, there is always a risk of local recurrence or distant metastasis, requiring ongoing surveillance.

Underlying Disease Risk

Low. Submandibular gland cancer is primarily a sporadic event. While some risk factors exist (e.g., prior radiation exposure), there isn't a strong association with specific common underlying systemic diseases.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.